Joanne Brodfuehrer

1.6k total citations
36 papers, 934 citations indexed

About

Joanne Brodfuehrer is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Joanne Brodfuehrer has authored 36 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Pharmacology. Recurrent topics in Joanne Brodfuehrer's work include Drug Transport and Resistance Mechanisms (9 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Computational Drug Discovery Methods (5 papers). Joanne Brodfuehrer is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Computational Drug Discovery Methods (5 papers). Joanne Brodfuehrer collaborates with scholars based in United States, China and South Korea. Joanne Brodfuehrer's co-authors include Ayman El‐Kattan, Cho‐Ming Loi, Susan Hurst, Dennis J. McNamara, Tong Zhu, Derek Sheehan, Patricia J. Harvey, Paul R. Keller, David W. Fry and Mark R. Barvian and has published in prestigious journals such as Cancer, Annals of the New York Academy of Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Joanne Brodfuehrer

36 papers receiving 908 citations

Peers

Joanne Brodfuehrer
Xianhua Cao United States
Bianca M. Liederer United States
Jason Boer United States
Nicola Colclough United Kingdom
Yang Sai China
Tanya Coleman United Kingdom
Dean Hickman United States
Rowan Stringer Switzerland
Xianhua Cao United States
Joanne Brodfuehrer
Citations per year, relative to Joanne Brodfuehrer Joanne Brodfuehrer (= 1×) peers Xianhua Cao

Countries citing papers authored by Joanne Brodfuehrer

Since Specialization
Citations

This map shows the geographic impact of Joanne Brodfuehrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne Brodfuehrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne Brodfuehrer more than expected).

Fields of papers citing papers by Joanne Brodfuehrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne Brodfuehrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne Brodfuehrer. The network helps show where Joanne Brodfuehrer may publish in the future.

Co-authorship network of co-authors of Joanne Brodfuehrer

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne Brodfuehrer. A scholar is included among the top collaborators of Joanne Brodfuehrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne Brodfuehrer. Joanne Brodfuehrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farrokhi, Vahid, Jason Walsh, Joe Palandra, et al.. (2021). Dystrophin and mini-dystrophin quantification by mass spectrometry in skeletal muscle for gene therapy development in Duchenne muscular dystrophy. Gene Therapy. 29(10-11). 608–615. 17 indexed citations
2.
Brodfuehrer, Joanne, Andrew L. Rankin, Jason Edmonds, et al.. (2013). Quantitative Analysis of Target Coverage and Germinal Center Response by a CXCL13 Neutralizing Antibody in a T-Dependent Mouse Immunization Model. Pharmaceutical Research. 31(3). 635–648. 17 indexed citations
3.
Rajadhyaksha, Manoj, Tracey Boyden, Jennifer L. Liras, Ayman El‐Kattan, & Joanne Brodfuehrer. (2011). Current Advances in Delivery of Biotherapeutics Across the Blood-Brain Barrier. Current Drug Discovery Technologies. 8(2). 87–101. 31 indexed citations
4.
Miller, Emily, David B. Duignan, Joanne Brodfuehrer, et al.. (2010). Understanding the clinical pharmacokinetics of a GABAApartial agonist by application ofin vitrotools. Xenobiotica. 40(7). 476–484. 4 indexed citations
5.
Cai, Hongliang, Arun K. Agrawal, David A. Putt, et al.. (2009). Assessment of the renal toxicity of novel anti-inflammatory compounds using cynomolgus monkey and human kidney cells. Toxicology. 258(1). 56–63. 14 indexed citations
7.
Hurst, Susan, Cho‐Ming Loi, Joanne Brodfuehrer, & Ayman El‐Kattan. (2007). Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans. Expert Opinion on Drug Metabolism & Toxicology. 3(4). 469–489. 74 indexed citations
8.
Stoner, Chad, Eric Gifford, Charles J. Stankovic, et al.. (2004). Implementation of an ADME enabling selection and visualization tool for drug discovery. Journal of Pharmaceutical Sciences. 93(5). 1131–1141. 30 indexed citations
9.
Stoner, Chad, Adriaan Cleton, Kjell Johnson, et al.. (2003). Integrated oral bioavailability projection using in vitro screening data as a selection tool in drug discovery. International Journal of Pharmaceutics. 269(1). 241–249. 41 indexed citations
10.
Cleton, Adriaan, et al.. (2002). Evaluation of the human serum albumin column as a discovery screening tool for plasma protein binding. European Journal of Pharmaceutical Sciences. 15(2). 209–215. 25 indexed citations
11.
Brodfuehrer, Joanne, et al.. (1998). Achiral and chiral high-performance liquid chromatographic methods for clinafloxacin, a fluoroquinolone antibacterial, in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 709(2). 265–272. 17 indexed citations
12.
Bullen, William W., Lloyd R. Whitfield, Gary A. Walter, & Joanne Brodfuehrer. (1995). High-performance liquid chromatographic assay for CI-980, a novel 1-deaza-7,8-dihydropteridine anticancer agent, in human plasma and urine. Journal of Chromatography B Biomedical Sciences and Applications. 668(1). 141–151. 4 indexed citations
13.
Poplin, Elizabeth, Michael Kraut, Laurence H. Baker, Joanne Brodfuehrer, & Vainutis K. Vaitkevicius. (1991). A dose-intensive regimen of 5-fluorouracil for the treatment of metastatic colorectal carcinoma. Cancer. 67(2). 367–371. 9 indexed citations
14.
Brodfuehrer, Joanne, et al.. (1990). Flavone acetic acid and plasma protein binding. Cancer Chemotherapy and Pharmacology. 27(1). 27–32. 7 indexed citations
15.
Brodfuehrer, Joanne, et al.. (1990). Comparative studies of the in vitro metabolism and covalent binding of 14C-benzene by liver slices and microsomal fraction of mouse, rat, and human.. Drug Metabolism and Disposition. 18(1). 20–27. 26 indexed citations
16.
Brodfuehrer, Joanne, et al.. (1989). Preclinical pharmacologic studies of the new antitumor agent carmethizole (NSC-602668) in the mouse and beagle dog. Cancer Chemotherapy and Pharmacology. 24(5). 277–283. 2 indexed citations
17.
Brodfuehrer, Joanne, et al.. (1988). In vitro cytotoxicity of pyrazine-2-diazohydroxide: specificity for hypoxic cells and effects of microsomal coincubation. Investigational New Drugs. 6(1). 3–9. 10 indexed citations
18.
Brodfuehrer, Joanne & Garth Powis. (1988). Gas chromatographic assay for the new antitumor agent sulfamic acid diester (NSC 329680) and its stability in buffer, blood and plasma. Journal of Chromatography B Biomedical Sciences and Applications. 427(2). 247–255. 2 indexed citations
19.
Brodfuehrer, Joanne & Vincent G. Zannoni. (1987). Flavin-containing monooxygenase and ascorbic acid deficiency. Biochemical Pharmacology. 36(19). 3161–3167. 5 indexed citations
20.
Brodfuehrer, Joanne. (1986). Ascorbic Acid And The Flavin-containing Monooxygenase.. Deep Blue (University of Michigan). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026